Carmen
De Mendoza Fernandez
Forscherin in der Zeit 2019-2022
Hospital Clinic Barcelona
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Clinic Barcelona (8)
2014
-
HIV-2 and HTLV-1 infections in Spain, a non-endemic region
AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159
2013
-
Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies
AIDS, Vol. 27, Núm. 1, pp. 81-85
2012
-
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy
Retrovirology, Vol. 9
-
Prevalence of xenotropic murine leukemia virus-related virus infection in different risk populations in Spain
AIDS Research and Human Retroviruses, Vol. 28, Núm. 9, pp. 889-894
-
Short communication: RNASEL alleles and susceptibility to infection by human retroviruses and hepatitis viruses
AIDS Research and Human Retroviruses, Vol. 28, Núm. 10, pp. 1259-1261
2010
-
Drug resistance mutations in HIV-infected patients in the Spanish drug resistance database failing tipranavir and darunavir therapy
Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 3018-3020
-
Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database
AIDS, Vol. 24, Núm. 3, pp. 469-471
2005
-
Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients
Journal of Medical Virology, Vol. 77, Núm. 1, pp. 23-28